Intracellular expression of antisense RNA. transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells

被引:13
作者
Barnor, JS
Miyano-Kurosaki, N
Yamaguchi, K
Sakamoto, A
Ishikawa, K
Inagaki, Y
Yamamoto, N
Osei-Kwasi, M
Ofori-Adjei, D
Takaku, H
机构
[1] Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan
[3] Noguchi Mem Inst Med Res, Dept Virol, Accra, Ghana
[4] Tokyo Med & Dent Univ, Tokyo, Japan
基金
日本学术振兴会;
关键词
HIV-1; vif; antisense RNA; inhibition of HIV-1 replication; gene therapy;
D O I
10.1016/j.bbrc.2004.05.201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type-1 (HIV-1)-encoded vif protein is essential for viral replication, virion production, and pathogenicity. HIV-1 vif interacts with the endogenous human APOBEC3G protein (an mRNA editor) in target cells to prevent its virions from encapsidation. Although some studies have established targets within the HIV-1 vif gene that are important for its biologic function, it is however important to further screen for effective therapeutic targets in the vif gene that could interfere with the HIV-1 vif-dependent infectivity and pathogenicity. This report demonstrates that HIV-1 vif antisense RNA fragments constructed within mid-3' region, notably the region spanning nucleic acid positions 5561-5705 (M-3'-AS), significantly inhibited HIV-1 replication in MT-4 and H9-infected cells and reduced the HIV-1 vif mRNA transcripts. These data clearly suggest that the above vif fragment, which corresponds to amino acid residues 96-144, could be an effective novel therapeutic target site for gene therapy applications, for the control and management of HIV-1 infection, due to its strong inhibition of HIV-1 replication in cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:544 / 550
页数:7
相关论文
共 42 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection [J].
Biasolo, MA ;
Radelli, A ;
DelPup, L ;
Franchin, E ;
DeGiuliMorghen, C ;
Palu, G .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2154-2161
[3]  
BRIDGES SH, 1995, LANCET, V345, P427, DOI 10.1016/S0140-6736(95)90407-7
[4]   Antisense RNA sequences targeting the 5′ leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle [J].
Chadwick, DR ;
Lever, AML .
GENE THERAPY, 2000, 7 (16) :1362-1368
[5]  
CHANG HK, 1994, GENE THER, V1, P208
[6]   Feline immunodeficiency virus Vif localizes to the nucleus [J].
Chatterji, U ;
Grant, CK ;
Elder, JH .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2533-2540
[7]   INHIBITION OF HIV-1 MULTIPLICATION IN A HUMAN CD4+ LYMPHOCYTIC CELL-LINE EXPRESSING ANTISENSE AND SENSE RNA MOLECULES CONTAINING HIV-1 PACKAGING SIGNAL AND REV RESPONSE ELEMENT(S) [J].
COHLI, H ;
FAN, B ;
JOSHI, RL ;
RAMEZANI, A ;
LI, XY ;
JOSHI, S .
ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (01) :19-26
[8]   Association of human immunodeficiency virus type 1 vif with RNA and its role in reverse transcription [J].
Dettenhofer, M ;
Cen, S ;
Carlson, BA ;
Kleiman, L ;
Yu, XF .
JOURNAL OF VIROLOGY, 2000, 74 (19) :8938-8945
[9]  
Ding SF, 2002, FRONT BIOSCI, V7, P15
[10]   Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins [J].
Fouchier, RAM ;
Simon, JHM ;
Jaffe, AB ;
Malim, MH .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8263-8269